Sodium Storage in Singaporeans

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-02

Study Completion Date

2035-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching hypothesis of this study is that the kidney and the skin form an integrative network for water conservation, where Na+ storage is utilized to prevent body water loss, even at the expense of increased cardiovascular risk. The aim of this project is to characterise skin and muscle Na+ storage in a cohort designed to prospectively measure cardiovascular outcomes in Singaporeans, in order to determine whether humans with increased tissue Na+ storage have increased cardiovascular risk. To gain a better understanding of the mechanisms behind Na+ storage, the investigators will also test the hypothesis that participants with mutations of the skin protein filaggrin, who have increased water loss through the skin, will have increased skin Na+ storage and higher blood pressure levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

NCT06569589

Hypertension Primary Aldosteronism Hypokalemia

RECRUITING

Skin Sodium and Salt Sensitivity of Blood Pressure

NCT05976438

Hypertension

UNKNOWN NA

The Role of Skin Sodium Accumulation in Chronic Kidney Disease

NCT07020104

Chronic Kidney Diseases

RECRUITING NA

Asian Diabetes Outcomes Prevention Trial

NCT04286399

Diabetes Mellitus Cardiovascular Diseases

RECRUITING PHASE4

Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function

NCT00405639

Heart Failure Asymptomatic Systolic Dysfunction

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular disease (CVD) occurs with increasing age and is the leading cause of death worldwide. A causal relationship between salt and CVD, although well established in animal models, has been difficult to prove in human populations. First, because humans do not live under the strict experimental conditions necessary to quantify sodium intake, and second, because tissue sodium stores cannot be detected with the available clinical methods, making reliable measurements of total body sodium extremely challenging.

The investigators have previously implemented 23NaMRI technology to detect and quantify tissue Na+ stores in humans. Previous studies have sown that humans store large amounts of Na+ in their skin and muscle as they age and that skin Na+ storage is linked with hypertension, while muscle Na+ storage is coupled with insulin resistance and diabetes. More recent studies show that the adverse effect of Na+ on human health goes far beyond the well-established salt-blood pressure relationship. The investigators have found that urea and/or Na+ storage in barriers such as kidney or skin is a key principle of water conservation.

This study aims to test the hypothesis that water conservation in the skin is essential for systemic fluid and blood pressure homeostasis, and that skin Na+ storage is utilized to prevent water loss, even at the expense of increased cardiovascular risk.

This is a cross-sectional study design with one study visit and a recruitment period of 3 years. 600 participants will be recruited from the Biobank cohort and tissue Na+ will be measured using 23NaMRI. The study will test whether increased Na+ storage in the skin is coupled with transepidermal water loss at the expense of high blood pressure levels, and examine the association between tissue sodium storage and specific cardiovascular markers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy

Eligible participants from the Biobank cohort at the National Heart Centre, Singapore, will be screened will be recruited for the study over a period of 3 years.

No interventions assigned to this group

Hypertensive

Eligible participants from the Biobank cohort at the National Heart Centre, Singapore, will be screened will be recruited for the study over a period of 3 years

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participants from the Biobank (Molecular and Imaging Studies of Cardiovascular Health and Disease) cohort in Singapore, who agreed to be contacted for further studies
2. Male and female patients older than 21 years
3. Willingness to participate and ability to provide informed consent

Exclusion Criteria

1. implanted devices (surgical clips, heart pacemakers or defibrillators, cochlear implants)
2. iron-based tattoos
3. any other pieces of metal or devices that are not MR-Safe anywhere in the body
4. patients who exhibit noticeable anxiety and/or claustrophobia into the MRI scanner
2. Pregnant women
3. Diagnosis of heart failure NYHA classes III and IV
4. Impaired renal function with eGFR\<45 ml/min or proteinuria \> 0.5 g/24h
5. Liver disease with cirrhosis (Child-Pugh class C) or hypoalbuminemia
6. Peripheral oedema as assessed by the investigator
7. Active cancer
8. Patients who have received an organ or bone marrow transplant
9. Patients who have had major surgery in the past 3 months
10. Patients who have severe comorbid conditions likely to compromise survival or study participation
11. Unwillingness or other inability to cooperate

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes